A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
Zhao H, et al. Among authors: meng k.
Oncotarget. 2015 Oct 13;6(31):31927-43. doi: 10.18632/oncotarget.5578.
Oncotarget. 2015.
PMID: 26376676
Free PMC article.